Status:
COMPLETED
Effects of Supplementation With Tocotrienol on Chronic Kidney Disease Patients
Lead Sponsor:
Universidade Federal Fluminense
Collaborating Sponsors:
Wayne State University
Conditions:
Chronic Kidney Diseases
Hemodialysis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The objective of this study is to evaluate the supplementation with tocotrienol, a vitamin E compound on inflammation, oxidative stress, and microbiota on Chronic Kidney Disease patients.
Detailed Description
In Chronic Kidney Disease (CKD), inflammation and oxidative stress are common statuses, which are aggravated by renal replacement therapy such as hemodialysis. Currently, intestinal microbiota imbalan...
Eligibility Criteria
Inclusion
- Chronic kidney disease
- Aged from 18 to 60 years
- Must be able to swallow capsules
Exclusion
- Pregnant patients
- Smokers
- Using antibiotics in the last 3 months
- Using antioxidant supplements in the last 3 months
- Usual intake Autoimmune
- Hemodialysis started less than 6 months for hemodialysis patients
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT04900532
Start Date
May 1 2019
End Date
December 31 2023
Last Update
February 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Denise Mafra
Rio de Janeiro, Rio de Janeiro, Brazil, 22260050